We are live on ! Find out more
ESRX

Express Scripts Holding Company
ESRX

Delisted

ESRX was delisted on the 20th of December, 2018.

1,253 hedge funds and large institutions have $58B invested in Express Scripts Holding Company in 2015 Q2 according to their latest regulatory filings, with 96 funds opening new positions, 455 increasing their positions, 473 reducing their positions, and 58 closing their positions.

New
Increased
Maintained
Reduced
Closed

114% more call options, than puts

Call options by funds: $962M | Put options by funds: $449M

66% more first-time investments, than exits

New positions opened: 96 | Existing positions closed: 58

6% more capital invested

Capital invested by funds: $54.9B → $58B (+$3.18B)

4% more funds holding in top 10

Funds holding in top 10: 102106 (+4)

2% more funds holding

Funds holding: 1,2261,253 (+27)

4% less repeat investments, than reductions

Existing positions increased: 455 | Existing positions reduced: 473

Holders
1,253
Holders Change
+27
Holders Change %
+2.2%
% of All Funds
33.76%
Holding in Top 10
106
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+3.92%
% of All Funds
2.86%
New
96
Increased
455
Reduced
473
Closed
58
Calls
$962M
Puts
$449M
Net Calls
+$513M
Net Calls Change
+$425M
Name Holding Trade Value Shares
Change
Change in
Stake
DBT
1126
Dubuque Bank & Trust
Iowa
$211K +$35.8K +410 +21%
MCM
1127
Manchester Capital Management
Vermont
$209K
ID
1128
Integral Derivatives
New York
$209K +$205K +2,349 New
LC
1129
Lourd Capital
California
$208K +$205K +2,342 New
BFA
1130
Bragg Financial Advisors
North Carolina
$207K +$203K +2,324 New
NPIT
1131
National Penn Investors Trust
Pennsylvania
$207K +$204K +2,333 New
CS
1132
Credential Securities
$205K +$98.3K +1,125 +95%
RCM
1133
RNC Capital Management
California
$205K -$87.4K -1,000 -30%
AA
1134
Ancora Advisors
Ohio
$205K +$201K +2,300 New
DFIM
1135
Detwiler Fenton Investment Management
Massachusetts
$205K +$202K +2,307 New
ZB
1136
Zions Bancorporation
Utah
$203K +$99.2K +1,136 +99%
QCI
1137
Quaker Capital Investments
Pennsylvania
$203K +$200K +2,288 New
LWA
1138
Lowe Wealth Advisors
Maryland
$202K
SIM
1139
SSI Investment Management
California
$202K +$198K +2,266 New
WPW
1140
Waldron Private Wealth
Pennsylvania
$201K +$198K +2,263 New
WOC
1141
West Oak Capital
California
$200K
MWP
1142
MYCIO Wealth Partners
Pennsylvania
$196K +$2.18K +25 +1%
HFM
1143
Hartford Financial Management
Connecticut
$192K +$189K +2,160 New
SAMC
1144
Shinko Asset Management Company
Japan
$189K -$14K -160 -7%
TRCT
1145
Tower Research Capital (TRC)
New York
$188K -$408K -4,668 -69%
BAM
1146
Barrett Asset Management
New York
$187K
MUS
1147
Mitsubishi UFJ Securities
Japan
$181K +$68.1K +780 +62%
Lazard Asset Management
1148
Lazard Asset Management
New York
$180K +$8.74K +100 +5%
Manulife (Manufacturers Life Insurance)
1149
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$180K +$13.7M +157,394 +8%
DSI
1150
Daiwa SB Investments
Japan
$170K

ESRX Hedge Fund Activity: Q2 2015 in Review

1,253 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Express Scripts Holding Company (ESRX) for Q2 2015, worth a combined $58B — up 5.8% from $54.9B a quarter earlier.

Buyers outnumbered sellers: 96 funds opened new ESRX positions and 58 closed out — a net gain of 38 holders — while 455 added to existing stakes and 473 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $2.7B. The largest seller was Grantham, Mayo, Van Otterloo & Co (GMO), cutting an estimated $909M.

  • 1,253 institutional investors held Express Scripts Holding Company (ESRX) as of Q2 2015, up from 1,226 in Q1 2015.
  • Funds reported $58B of Express Scripts Holding Company stock for Q2 2015, up 5.8% quarter-over-quarter.
  • 96 funds opened new Express Scripts Holding Company positions in Q2 2015 and 58 closed out, a net change of +38 holders.
  • The largest Express Scripts Holding Company buyer in Q2 2015 was Morgan Stanley, an estimated $2.7B added.
  • The largest Express Scripts Holding Company seller in Q2 2015 was Grantham, Mayo, Van Otterloo & Co (GMO), an estimated $909M sold.

Based on aggregated 13F filings for Q2 2015.